JPM vs WULF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
TeraWulf exhibits critical financial instability, highlighted by a Piotroski F-Score of 1/9, indicating severe deterioration in fundamental health. The company's valuation is completely detached from its operational reality, with a Price/Sales ratio of 59.24 and a Forward P/E of 5092.50 despite an operating margin of -210.53%. While analysts maintain a 'strong_buy' rating and historical price action has been explosive, the combination of catastrophic EPS growth (-800% YoY) and significant insider selling by the CEO and CFO suggests a speculative bubble.
Compare Another Pair
Related Comparisons
JPM vs WULF: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and TeraWulf Inc. (WULF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.